425 related articles for article (PubMed ID: 6853711)
1. Natural killer cell in systemic lupus erythematosus. Defects in effector lytic activity and response to interferon and interferon inducers.
Sibbitt WL; Mathews PM; Bankhurst AD
J Clin Invest; 1983 May; 71(5):1230-9. PubMed ID: 6853711
[TBL] [Abstract][Full Text] [Related]
2. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus.
Sibbitt WL; Mathews PM; Bankhurst AD
Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394
[TBL] [Abstract][Full Text] [Related]
3. Interferon-alpha regulation of lymphocyte function in systemic lupus erythematosus.
Sibbitt WL; Froelich CJ; Bankhurst AD
Clin Immunol Immunopathol; 1984 Jul; 32(1):70-80. PubMed ID: 6733982
[TBL] [Abstract][Full Text] [Related]
4. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis.
Neighbour PA; Grayzel AI; Miller AE
Clin Exp Immunol; 1982 Jul; 49(1):11-21. PubMed ID: 6181920
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells and interferon responses in patients with systemic lupus erythematosus.
Tsokos GC; Rook AH; Djeu JY; Balow JE
Clin Exp Immunol; 1982 Nov; 50(2):239-45. PubMed ID: 6817954
[TBL] [Abstract][Full Text] [Related]
6. Abnormal interferon modulation of natural cytotoxicity in systemic lupus erythematosus. Relation to suppressive serum factors.
Sibbitt WL; Froelich CJ; Bankhurst AD
Arthritis Rheum; 1983 Dec; 26(12):1452-9. PubMed ID: 6651894
[TBL] [Abstract][Full Text] [Related]
7. Natural cytotoxicity in systemic lupus erythematosus: mechanisms of suppression by inhibitory serum factors.
Sibbitt WL; Froelich CJ; Bankhurst AD
Clin Exp Immunol; 1983 Aug; 53(2):363-70. PubMed ID: 6883808
[TBL] [Abstract][Full Text] [Related]
8. [Effects of Astragalus membranaceus and Tripterygium hypoglancum on natural killer cell activity of peripheral blood mononuclear in systemic lupus erythematosus].
Zhao XZ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Nov; 12(11):669-71, 645. PubMed ID: 1301849
[TBL] [Abstract][Full Text] [Related]
9. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event.
Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S
J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439
[TBL] [Abstract][Full Text] [Related]
10. Impaired natural killer cell function in systemic lupus erythematosus. Relationship to interleukin-2 production.
Sibbitt WL; Likar L; Spellman CW; Bankhurst AD
Arthritis Rheum; 1983 Nov; 26(11):1316-20. PubMed ID: 6605749
[TBL] [Abstract][Full Text] [Related]
11. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
12. Relationship between circulating interferon and anti-interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus.
Sibbitt WL; Gibbs DL; Kenny C; Bankhurst AD; Searles RP; Ley KD
Arthritis Rheum; 1985 Jun; 28(6):624-9. PubMed ID: 2408630
[TBL] [Abstract][Full Text] [Related]
13. Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors.
Zippel D; Lackovic V; Kocisková D; Rovenský J; Borecký L; Stelzner A
Acta Virol; 1989 Sep; 33(5):447-53. PubMed ID: 2483602
[TBL] [Abstract][Full Text] [Related]
14. Natural cell mediated cytotoxicity in systemic lupus erythematosus: suppression by antilymphocyte antibody.
Goto M; Tanimoto K; Horiuchi Y
Arthritis Rheum; 1980 Nov; 23(11):1274-81. PubMed ID: 6969594
[TBL] [Abstract][Full Text] [Related]
15. Defective natural killer (NK) and killer (K) cell function in systemic lupus erythematosus.
Ewan PW; Barrett HM; Pusey CD
J Clin Lab Immunol; 1983 Feb; 10(2):71-6. PubMed ID: 6842577
[TBL] [Abstract][Full Text] [Related]
16. Family study of natural killer cell activity in C1q-deficient patients with systemic lupus erythematosus-like syndrome: association between impaired natural killer cell function and C1q deficiency.
Tóth J; Starsia Z; Buc M; Stefanovic J
Immunobiology; 1989 Nov; 180(1):47-54. PubMed ID: 2625354
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus.
Tsokos GC; Smith PL; Christian CB; Lipnick RN; Balow JE; Djeu JY
Clin Immunol Immunopathol; 1985 Mar; 34(3):379-86. PubMed ID: 3156017
[TBL] [Abstract][Full Text] [Related]
20. Diminished peripheral blood monocyte DR antigen expression in systemic lupus erythematosus.
Nagai H; Sztein MB; Steeg PS; Hooks JJ; Oppenheim JJ; Steinberg AD
Clin Exp Rheumatol; 1984; 2(2):131-7. PubMed ID: 6598101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
